Beclometasone jet nebuliser inhalation - Adams/Therapeutics 2000

Drug Profile

Beclometasone jet nebuliser inhalation - Adams/Therapeutics 2000

Alternative Names: Beclomethasone jet nebuliser inhalation - Adams/Therapeutics 2000

Latest Information Update: 06 Jun 2001

Price : $50

At a glance

  • Originator Therapeutics 2000
  • Developer Adams Respiratory Therapeutics; Therapeutics 2000
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Asthma; Emphysema

Most Recent Events

  • 06 Jun 2001 No-Development-Reported for Emphysema in USA (Inhalation)
  • 06 Jun 2001 No-Development-Reported for Asthma in USA (Inhalation)
  • 02 Nov 1998 Investigation in Emphysema in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top